Systems That Deliver Reliably: Advancing Integrated, Sustainable Pharma Operations at the 2026 ISPE Annual Meeting & Expo
The 2026 ISPE Annual Meeting & Expo, taking place 18–21 October in Washington, D.C., will convene global leaders across pharmaceutical engineering, manufacturing, and operations to address one of the industry’s most pressing challenges: how to design and operate systems that consistently deliver safe, high-quality therapies while reducing environmental impact and strengthening system resilience.
The “Systems That Deliver Reliably” track focuses on the evolution from functionally optimized operations to fully integrated, data-informed systems that align facilities, manufacturing, quality, and supply chain performance with sustainability goals. Increasingly, leading organizations are moving beyond treating sustainability as a reporting obligation and instead embedding environmental considerations (e.g., energy, water, materials, and emissions) directly into process design, engineering decisions, and lifecycle management.
The sessions within this track examine how organizations are embedding sustainability into core operational decisions and lifecycle management, demonstrating measurable outcomes in emissions reduction, resource efficiency, cost performance, and supply continuity. In parallel, the track investigates how digitalization, data integration, and emerging technologies such as Generative AI can enhance predictability, enable proactive risk management, and strengthen adaptive capacity across global value chains.
Embedding Sustainability into Operational Systems
A central theme across the track is the operationalization of sustainability within commercial manufacturing environments. Rather than focusing solely on incremental improvements, sessions examine how organizations are integrating environmental metrics into core performance frameworks, alongside traditional measures such as yield, uptime, and compliance.
A prominent example is AstraZeneca’s implementation of its Ambition Zero Carbon strategy at its flagship biologics site in Frederick, Maryland. The site achieved a 98% reduction in Scope 1 and 2 emissions relative to its 2015 baseline, while simultaneously scaling production by more than 600%. The technical significance lies not only in the outcome, but in the system-level coordination required across utilities, process design, and operational execution to achieve it. The session also addresses ongoing efforts to reduce Scope 3 emissions through supplier engagement, material optimization, and logistics redesign, highlighting the increasing importance of value chain integration.
Complementing this is a structured framework for advancing sustainable manufacturing performance through a maturity-based operational model. This approach integrates asset reliability, energy intensity, and digital monitoring into a unified improvement strategy. By establishing performance baselines, identifying systemic losses, and aligning interventions with capital planning cycles, organizations can transition from reactive optimization to scalable, continuously improving operations that support both reliability and decarbonization objectives.
Design-Led Approaches to Sustainability
The track underscores the importance of incorporating environmental considerations early in product and process design, where decisions have the greatest long-term impact. Rather than retrofitting sustainability improvements, leading organizations are applying data-driven modeling and lifecycle analysis to evaluate trade-offs across raw materials, manufacturing methods, and distribution strategies.
GSK’s EcoDesign framework provides a clear illustration of this approach. By assessing environmental impacts from raw material sourcing through end-of-life disposal, the framework enables identification of high-impact interventions and prioritization of changes such as bioprocess intensification and continuous manufacturing. These approaches often deliver dual benefits: reduced resource consumption alongside improved process control and consistency.
A related session focuses on the practical reality that implementation depends on robust business cases. Sustainability initiatives must compete for capital and organizational attention, requiring clear articulation of financial value, risk reduction, and regulatory alignment. Drawing on industry case studies, the session outlines methodologies for quantifying lifecycle costs, integrating environmental metrics into investment decisions, and addressing common barriers to approval.
Resource Stewardship as a Lever for Performance
Resource efficiency, particularly in the management of water and energy, emerges as a critical driver of both sustainability and operational performance. Multiple sessions examine how engineering-led interventions can significantly reduce resource consumption while enhancing system reliability.
Water, in particular, is highlighted as a strategically important but often undervalued resource. Applications such as cell culture, cleaning-in-place, and high-purity water generation can account for a substantial portion of facility demand. The application of reduce, reuse, and recycle strategies within these systems has been shown to deliver measurable benefits without compromising product quality.
Case studies presented in the track demonstrate this impact. One example reports 220 million liters of water savings, alongside USD$4 million in capital expenditure and USD$1.9 million in operational cost reductions over a ten-year period, achieved through front-end engineering optimization and continuous improvement initiatives. These results illustrate how resource stewardship can be embedded into system design and operational practice, rather than treated as a secondary consideration.
Further advances are demonstrated through the redesign of water-for-injection systems, where membrane-based technologies, heat recovery, and integrated sanitization strategies have improved energy efficiency, reduced emissions, and maintained good manufacturing practices (GMP) compliance. The emphasis is on aligning technology selection with actual operational demand, ensuring both performance and sustainability outcomes.
Integration and Digital Enablement
A key enabler of reliable, sustainable systems is the integration of data and operational platforms. In many pharmaceutical environments, critical systems, including enterprise asset management, quality management systems, and enterprise resource planning, remain siloed, limiting visibility and slowing decision-making.
Sessions within the track examine how cross-system data integration creates a more cohesive operational environment, enabling real-time insight into asset performance, quality events, and supply chain dynamics. This integrated approach supports predictive maintenance, faster deviation resolution, and improved planning, while also enabling tracking and optimization of environmental performance metrics.
Aligned with ISPE’s Pharma 4.0™ principles, these strategies emphasize data integrity, governance, and actionable analytics as foundations for continuous improvement and resilience.
Standardization, Modularity, and Scalability
The track also addresses the limitations of traditional standardization approaches in facility design and delivery. While standardized components and templates have improved consistency, they often fail to enable true scalability across projects.
A proposed platform-based delivery model shifts the focus toward modular process definitions, aligned automation architectures, and stable system interfaces, enabling reuse across multiple facilities. This approach reduces engineering redundancy, accelerates deployment timelines, and improves predictability in capital project execution.
Similarly, risk-based design methodologies are applied to single-use systems in biologics manufacturing. By quantifying sterile boundary risks and implementing modular, standardized configurations, organizations have achieved significant improvements in reliability, including an estimated 69% reduction in contamination risk.
Advancing the Industry Through Integrated Systems
A concluding panel synthesizes these themes, exploring how industry leaders are designing connected systems capable of operating reliably under increasing complexity and demand variability. Topics include the role of advanced analytics and AI in predicting system behavior, the integration of circular economy principles into operational decision-making, and the challenges of aligning cross-functional teams within a unified system model.
The “Systems That Deliver Reliably” track reflects a broader transformation within pharmaceutical manufacturing: a shift from isolated optimization toward holistic system design, where quality, reliability, and environmental performance are engineered together.
By integrating sustainability considerations into the same frameworks used to design and control processes, organizations are establishing more resilient, efficient, and future-ready operations. These approaches are essential for maintaining supply continuity, meeting regulatory expectations, and reducing environmental footprint, while continuing to deliver high-quality therapies to patients at scale.
Learn more and register for the 2026 ISPE Annual Meeting & Expo